BIOMAT Database Logo BIOMAT Database Logo

Extending non-invasive prenatal testing to non-invasive prenatal diagnosis. 2019

Rachel Helen Horton, and Diana Gay Wellesley
Wessex Clinical Genetics Service, G Level, Princess Anne Hospital, Southampton, UK.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D005260 Female Females
D005820 Genetic Testing Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing. Genetic Predisposition Testing,Genetic Screening,Predictive Genetic Testing,Predictive Testing, Genetic,Testing, Genetic Predisposition,Genetic Predictive Testing,Genetic Screenings,Genetic Testing, Predictive,Predisposition Testing, Genetic,Screening, Genetic,Screenings, Genetic,Testing, Genetic,Testing, Genetic Predictive,Testing, Predictive Genetic
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D042241 Early Diagnosis Methods to determine in patients the nature of a disease or disorder at its early stage of progression. Generally, early diagnosis improves PROGNOSIS and TREATMENT OUTCOME. Early Detection of Disease,Diagnosis, Early,Disease Early Detection
D020379 Risk Adjustment The use of severity-of-illness measures, such as age, to estimate the risk (measurable or predictable chance of loss, injury or death) to which a patient is subject before receiving some health care intervention. This adjustment allows comparison of performance and quality across organizations, practitioners, and communities. (from JCAHO, Lexikon, 1994) Case-Mix Adjustment,Adjustment, Case-Mix,Adjustment, Risk,Adjustments, Case-Mix,Adjustments, Risk,Case Mix Adjustment,Case-Mix Adjustments,Risk Adjustments

Related Publications

Rachel Helen Horton, and Diana Gay Wellesley
Non-invasive prenatal testing.
October 2017, Australian family physician,
Rachel Helen Horton, and Diana Gay Wellesley
Non-invasive prenatal testing.
April 1988, Canadian family physician Medecin de famille canadien,
Rachel Helen Horton, and Diana Gay Wellesley
Non-invasive prenatal testing (NIPT): limitations on the way to become diagnosis.
September 2015, Diagnosis (Berlin, Germany),
Rachel Helen Horton, and Diana Gay Wellesley
Non-invasive prenatal diagnosis.
January 2011, Methods in molecular biology (Clifton, N.J.),
Rachel Helen Horton, and Diana Gay Wellesley
Non-invasive prenatal diagnosis.
March 1994, Lancet (London, England),
Rachel Helen Horton, and Diana Gay Wellesley
Non-invasive prenatal testing: a revolutionary journey in prenatal testing.
January 2023, Frontiers in medicine,
Rachel Helen Horton, and Diana Gay Wellesley
Non-invasive prenatal testing: impact on invasive prenatal diagnosis at a mainland Chinese tertiary medical center.
November 2016, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
Rachel Helen Horton, and Diana Gay Wellesley
Lower detectability of non-invasive prenatal testing compared to prenatal diagnosis in high-risk pregnant women.
July 2019, Annals of translational medicine,
Rachel Helen Horton, and Diana Gay Wellesley
Update in non-invasive prenatal testing.
February 2019, Minerva ginecologica,
Rachel Helen Horton, and Diana Gay Wellesley
Non-Invasive Prenatal Testing beyond Trisomies.
January 2019, Journal of medicine and life,
Copied contents to your clipboard!